Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin

Sex: All

Ages: 18 Years – 65 Years

Healthy volunteers: No

Phase: NA

Enrollment: 50

Sponsor: Medical University of Bialystok

Location: Medical University of Bialystok, Department of Internal Medicine and Metabolic Diseases Bialystok

Summary

The aim of the study is to assess the influence of continuous glucose monitoring (CGM) systems on metabolic control and quality of life in people with type 2 diabetes and overweight/obesity who are not treated with insulin. Additionally, the study aims to assess the association between metabolic control of diabetes and markers of early cardiovascular disease, taking into account the impact of CGM use.

Eligibility Criteria

Inclusion Criteria: * Age between 18 and 65 years (both inclusive) * Type 2 diabetes diagnosed at least 6 months prior to entering the study * Body mass index ≥25 kg/m2 * Diabetes treated with oral medications and/or GLP-1 receptor agonists and/or tirzepatide * No modifications of diabetes treatment in the previous 3 months * HbA1c between 7.5% and 10% (both inclusive) * Oral and written informed consent for participation Exclusion Criteria: * Type 1 diabetes, gestational diabetes, other specific types of diabetes * HbA1c \>10.0% * Treatment with insulin * Previous use of any continuous glucose monitoring system * GFR \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07919236). StuddyBuddy aggregates publicly available trial information.